MicroRNA pharmacogenomics based integrated model of miR-17-92 cluster in sorafenib resistant HCC cells reveals a strategy to forestall drug resistance

Among solid tumors, hepatocellular carcinoma (HCC) emerges as a prototypical therapy-resistant tumor. Considering the emerging sorafenib resistance crisis in HCC, future studies are urgently required to overcome resistance. Recently noncoding RNAs (ncRNAs) have emerged as significant regulators in s...

Descripción completa

Detalles Bibliográficos
Autores principales: Awan, Faryal Mehwish, Naz, Anam, Obaid, Ayesha, Ikram, Aqsa, Ali, Amjad, Ahmad, Jamil, Naveed, Abdul Khaliq, Janjua, Hussnain Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597599/
https://www.ncbi.nlm.nih.gov/pubmed/28904393
http://dx.doi.org/10.1038/s41598-017-11943-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597599/
https://www.ncbi.nlm.nih.gov/pubmed/28904393
http://dx.doi.org/10.1038/s41598-017-11943-1

Ejemplares similares